HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 168 filers reported holding HAEMONETICS CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $408,395 | -6.5% | 4,559 | -11.2% | 0.31% | -47.5% |
| Q2 2023 | $436,938 | +84.2% | 5,132 | +79.0% | 0.58% | +88.1% |
| Q1 2023 | $237,244 | -4.8% | 2,867 | -9.5% | 0.31% | -6.6% |
| Q4 2022 | $249,242 | +5.6% | 3,169 | -0.4% | 0.33% | -5.9% |
| Q3 2022 | $236,000 | -30.2% | 3,183 | -38.7% | 0.35% | +19.3% |
| Q2 2022 | $338,000 | -37.3% | 5,191 | -39.1% | 0.30% | -36.9% |
| Q1 2022 | $539,000 | -33.6% | 8,519 | -44.4% | 0.47% | -32.9% |
| Q4 2021 | $812,000 | -6.7% | 15,309 | +24.2% | 0.70% | -13.2% |
| Q3 2021 | $870,000 | -4.6% | 12,327 | -10.0% | 0.80% | -3.8% |
| Q2 2021 | $912,000 | +1069.2% | 13,691 | +512.6% | 0.84% | -21.6% |
| Q3 2014 | $78,000 | -13.3% | 2,235 | -11.8% | 1.07% | +6.9% |
| Q2 2014 | $90,000 | – | 2,535 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |